Ayala Pharmaceuticals Inc (ADXS)

[jckrdu]

"Management can only create fear in the minds of shareholders and go for another mega dilution once it becomes clear there are no deals to be made."
_________________________________

IMO, worst case scenario is modest dilution (not mega-dilution) to buy enough time to generate preliminary Phase 1 results for NEO. Wildcards are AXAL/Cervical deal and milestone payment from AMGEN. If AXAL/cervical is wound-down, additional cost cutting and positive forward guidance could - ironically - be a catalyst.

The recent Affirmed/Genentech deal bodes well for ADXS, IMO. I didn't do a lot of due diligence on Affirmed, but it looks like they did have some Phase 1 and Phase 1b data/results, which IMO enabled the recent deal with Genentech.